Health: Clinical Trials News

Today is July 10, 2024. All times in Eastern Daylight Time.

Pint Pharma announces the approval of ORLADEYO® (berotralstat), the first oral therapy indicated to prevent hereditary angioedema (HAE) attacks in adults and children 12 years and older in Peru.

07/09/2024 - 10:35 PM

BUSINESS WIRE
MicroVention kündigt klinische Veröffentlichung von SOFAST an: SOFIA™ Absaugsystem als Erstlinientechnik bei der Behandlung des akuten ischämischen Schlaganfalls

07/09/2024 - 04:54 PM

BUSINESS WIRE
Resumen: MicroVention anuncia la publicación clínica del sistema de aspiración SOFAST: SOFIA™ como técnica de primera línea en el tratamiento del ictus isquémico agudo

07/09/2024 - 04:54 PM

BUSINESS WIRE
MicroVention annonce la publication clinique de SOFAST avec le système d'aspiration SOFIA™ comme technique de première intention dans le traitement de l'accident vasculaire cérébral ischémique aigu

07/09/2024 - 04:54 PM

BUSINESS WIRE
Riassunto: MicroVention annuncia la pubblicazione dello studio clinico SOFAST: il sistema di aspirazione SOFIA™ come tecnica di prima linea nel trattamento dell'ictus ischemico acuto

07/09/2024 - 02:52 PM

BUSINESS WIRE
Samenvatting: MicroVention kondigt klinische publicatie aan van SOFAST: SOFIA™ Aspiratiesysteem als eerstelijnstechniek bij de behandeling van acute ischemische beroerte

07/09/2024 - 02:48 PM

BUSINESS WIRE
Eurofins CDMO Alphora Inc. (Canada) Announces Completion of New API Manufacturing Facility

07/09/2024 - 02:00 PM

BUSINESS WIRE
Calorify Commercializes and Scales Doubly Labeled Water Test to Support Clinical Trial Researchers, Healthcare Providers, and Sports Physicians

07/09/2024 - 09:41 AM

BUSINESS WIRE
Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile

07/09/2024 - 09:10 AM

BUSINESS WIRE
Swing Therapeutics Announces The Lancet Publication of Data from Phase 3 Trial of Stanza™ - a Digital Behavioral Therapy for Fibromyalgia Symptoms

07/09/2024 - 09:00 AM

BUSINESS WIRE
MicroVention Announces Clinical Publication of SOFAST: SOFIA™ Aspiration System as First Line Technique in Treating Acute Ischemic Stroke

07/09/2024 - 09:00 AM

BUSINESS WIRE
Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine

07/09/2024 - 08:30 AM

BUSINESS WIRE
ReAlta Life Sciences Strengthens Board of Directors with Appointment of Accomplished Financial Executive

07/09/2024 - 08:30 AM

BUSINESS WIRE
One A Day® Launches Science-Backed Cellular Aging Support Supplement

07/09/2024 - 08:02 AM

BUSINESS WIRE
Imbrium Therapeutics Achieves Last Patient Last Visit in Clinical Trial of Potential Treatment for Overactive Bladder Syndrome

07/09/2024 - 08:00 AM

BUSINESS WIRE
Obsidian Therapeutics Announces FDA Fast Track Designation for OBX-115 for the Treatment of Advanced Melanoma

07/09/2024 - 08:00 AM

BUSINESS WIRE
Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

07/09/2024 - 08:00 AM

BUSINESS WIRE
bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung

07/09/2024 - 08:00 AM

BUSINESS WIRE
Jaguar Gene Therapy to Initiate Inaugural Pediatric Clinical Trial Targeting a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome

07/09/2024 - 08:00 AM

BUSINESS WIRE
S.BIOMEDICS Dopamine Cell Therapy for Parkinson’s Disease with TED-A9 Shows Promising Results at 12 months in Phase I/IIa Clinical Trial

07/09/2024 - 07:00 AM

BUSINESS WIRE
Precision Neuromodulation Decreased Brain Atrophy and Increased Connectivity in Key Brain Network in Alzheimer’s Patients

07/09/2024 - 07:00 AM

BUSINESS WIRE
Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products

07/09/2024 - 07:00 AM

BUSINESS WIRE
Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development

07/09/2024 - 06:45 AM

BUSINESS WIRE
Galderma Introduces High Potency Cetaphil Serums Designed for Sensitive Skin

07/09/2024 - 01:07 AM

BUSINESS WIRE
Pint Pharma anuncia la aprobación de ORLADEYO® (berotralstat), la primera terapia oral indicada para prevenir los ataques de angioedema hereditario (HAE) en pacientes adultos y pediátricos de 12 años en adelante en Peru.

07/08/2024 - 06:34 PM

BUSINESS WIRE

1 2 3 4 5 6 7 8 9 10 11 ... 24

Next »

Search